Villaroya, Jeane C.
HRN: 22-12-72 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/06/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
11/06/2022
11/12/2022
PO
500mg
TID
LTCS
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes